Alzheimer disease

Some of the articles featured in the September 2019 edition of RGA's Global Medical Newsletter include:

• Part II: Proposed New Classification and Nomenclature for Chronic Pain
• The Changing Face of Alzheimer’s Disease
• Brief Report: The Elusive Influenza Vaccine – Are We Any Closer?

For a long time, Alzheimer’s could only be definitively diagnosed after a patient’s death based on neuropathological findings in the brain. Positron emission tomography (PET) scanning and spinal fluid technologies can improve on purely clinical diagnosis, but their cost and a lack of any cure means they are hardly used.

Slides from Dr. Brian Ivanovic’s presentation at the SOA Underwriting Issues & Innovations Seminar, Aug 1-2, 2016 in Chicago have been posted.

https://www.soa.org/Professional-Development/Event-Calendar/2016/underwr...
(Go to “Medical Topics” at the 8:05-9:40am time slot to download PDF)

Dementia is associated with growing old and has a devastating impact on individuals’ capacity to self-care. The organization Alzheimer’s Disease International projects there will be more than 75 million people with dementia worldwide by 2030.

http://www.genre.com/knowledge/blog/is-dementia-just-gradually-slowing-d...